Kidney diseases are a global public health problem, with an incidence that has reached epidemic proportions and continues to climb in the USA and worldwide. This trend is projected to grow in correlation with the global rise in the aged population and the increasing prevalence of conditions that cause renal complications, such as cardiovascular disease, hypertension, and diabetes. Current treatment options for acute and chronic kidney disease include dialysis, which is also associated with substantial morbidity and mortality, and kidney transplantation, which is limited by the supply of compatible organs. Consequently, new methods to alleviate, cure, or prevent renal disease are urgently required to reduce the exponentially growing burden due to acute and chronic kidney disorders and offer alternative therapeutic options to improve patients' survival and quality of life. Several potential regenerative cell-based therapies for the treatment of renal failure are currently under development. The first one is the direct application of stem cells (SCs) to the diseased kidney, which relies on the inherent capabilities of SCs to differentiate, organize, and integrate into the existing tissues to restore function. To this aim different stem cell types have been investigated for their potential to contribute to renal regeneration. The editors hope that the original and review articles integrated in this special issue provide more insights into the advancements and challenges faced by this rapidly expanding field of regenerative medicine and will be helpful and educational for interested readers.
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